Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma.
作者信息
D'Arco Alfonso Maria, Califano Catello, Barone Lucia, Belsito Petrizzi Valeria, Iovino Vincenzo, Langella Maria, Maglione Valentina, Rivellini Flavia, De Lorenzo Sonya
机构信息
Onco-Haematology Unit, Nocera-Pagani, SA, Italy.
出版信息
Br J Haematol. 2015 Nov;171(4):662-5. doi: 10.1111/bjh.13429. Epub 2015 Apr 14.
PMID:25873239
Abstract
摘要
相似文献
1
Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma.剂量密集和剂量强度ABVD方案用于晚期高危霍奇金淋巴瘤患者的可行性和疗效
Br J Haematol. 2015 Nov;171(4):662-5. doi: 10.1111/bjh.13429. Epub 2015 Apr 14.
2
Advanced Hodgkin's disease: ABVD is better, yet is not good enough!晚期霍奇金淋巴瘤：阿霉素、博来霉素、长春花碱和达卡巴嗪联合化疗方案（ABVD）疗效更佳，但仍不尽人意！
J Clin Oncol. 2003 Feb 15;21(4):583-5. doi: 10.1200/JCO.2003.11.072.
3
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.ABVD方案与MOPP/ABV混合方案治疗晚期霍奇金淋巴瘤的随机对照研究：一项多组间试验报告
J Clin Oncol. 2003 Feb 15;21(4):607-14. doi: 10.1200/JCO.2003.12.086.
4
Prophylactic use of filgrastim with ABVD and BEACOPP chemotherapy regimens for Hodgkin lymphoma.
Clin Lymphoma Myeloma. 2007 Dec;8 Suppl 2:S63-6. doi: 10.3816/clm.2007.s.035.
5
Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.高危霍奇金淋巴瘤患者的早期强化与晚期强化——3周期强化化疗加低剂量淋巴结放射治疗与4周期多柔比星、博来霉素、长春碱和达卡巴嗪联合大剂量化疗及自体干细胞移植：代表GOELAMS组的一项随机试验的五年结果
Cancer. 2008 Dec 15;113(12):3323-30. doi: 10.1002/cncr.23979.
6
Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma: reply to D'Arco et al.
Br J Haematol. 2015 Nov;171(4):665-8. doi: 10.1111/bjh.13430. Epub 2015 Apr 19.
7
[Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].[癌症的成功化疗。霍奇金病的缓解。IV]
Clin Ter. 2001 May-Jun;152(3):203-6.
8
A phase II study of dose-dense and dose-intense ABVD (ABVDDD-DI ) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma.一项在晚期霍奇金淋巴瘤患者中不进行巩固性放疗的密集 ABVD（ABVDDD-DI）剂量递增和剂量密集方案的 II 期研究。
Br J Haematol. 2014 Jul;166(1):118-29. doi: 10.1111/bjh.12862. Epub 2014 Mar 27.
9
Early intensification treatment approach in advanced-stage Hodgkin lymphoma.晚期霍奇金淋巴瘤的早期强化治疗方法。
Hematol Oncol Clin North Am. 2014 Feb;28(1):65-74. doi: 10.1016/j.hoc.2013.10.002.
10
How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?博来霉素在阿霉素+博来霉素+长春花碱+达卡巴嗪方案中有多重要？
J Clin Oncol. 2004 Apr 15;22(8):1532-3. doi: 10.1200/JCO.2004.99.010.
引用本文的文献
1
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study.脂质体多柔比星强化含一线治疗晚期弥漫性大 B 细胞淋巴瘤或经典霍奇金淋巴瘤患者：单中心 II 期研究的初步结果。
Br J Haematol. 2022 Sep;198(5):847-860. doi: 10.1111/bjh.18348. Epub 2022 Jul 12.
Zotero 插件